Cargando…

Adverse drug reactions due to ophthalmic drugs: Reporting system in India

Detalles Bibliográficos
Autores principales:	Kalaiselvan, Vivekanandan, Mishra, Prabhakar, Singh, Gyanendra Nath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869476/ https://www.ncbi.nlm.nih.gov/pubmed/27146948 http://dx.doi.org/10.4103/0301-4738.181738

Ejemplares similares

System of adverse drug reactions reporting: What, where, how, and whom to report?
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2015)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
por: Prakash, Jai, et al.
Publicado: (2019)

Implementation of adverse event reporting for medical devices, India
por: Shukla, Shatrunajay, et al.
Publicado: (2020)

Pharmacovigilance Programme of India: Recent developments and future perspectives
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Intraocular devices associated adverse events reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2020)

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018)

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
por: Rastogi, Shruti, et al.
Publicado: (2022)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
por: Kumar, Pramod, et al.
Publicado: (2017)

Adverse drug reaction and causality assessment scales
por: Zaki, Syed Ahmed
Publicado: (2011)

Clinical causality assessment for adverse drug reactions
por: Parida, Satyen
Publicado: (2013)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India
por: Panja, Buddhadev, et al.
Publicado: (2015)

Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians
por: Sickmüller, Barbara, et al.
Publicado: (2013)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reactions of itolizumab in COVID-19 patient: A case report
por: Mohammed, Ziauddin, et al.
Publicado: (2022)

Adverse drug reaction monitoring in psychiatry out-patient
por: Tandon, Vishal
Publicado: (2012)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Postgraduate ophthalmic education in India?
por: Parikh, Rajul S
Publicado: (2009)

Discouraging adverse drug reactions reporting culture: Just a tip of the ‘Gullible Prescribing’
por: Mohammed, Imran
Publicado: (2013)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Ophthalmic biosimilars: Lessons from India
por: Sharma, Ashish, et al.
Publicado: (2019)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Adverse drug reactions with naltrexone: Experience from an addiction treatment center
por: Sarkar, Siddharth, et al.
Publicado: (2021)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
por: Khan, Zakir, et al.
Publicado: (2022)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Adverse reactions to nonsteroidal anti-inflammatory drugs and hypersensitivity to lipid transfer proteins
por: Nucera, Eleonora, et al.
Publicado: (2016)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
por: Tang, Mi, et al.
Publicado: (2021)

Development of phimosis as an adverse drug reaction to capecitabine with irinotecan
por: Patel, Priyeshkumar, et al.
Publicado: (2022)

An analysis of completeness and quality of adverse drug reaction reports at an adverse drug reaction monitoring centre in Western India
por: Mahajan, Manali Mangesh, et al.
Publicado: (2018)

Club Drugs in India: An Analysis of Newspaper Reports
por: Kathiresan, Preethy, et al.
Publicado: (2021)

Tramadol-Related Adverse Drug Reactions at an Addiction Psychiatry Setting: A Cross-Sectional Analysis
por: Dhagudu, Naveen Kumar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0pv6g52uhbhdjehoc4ni235gl5